3 Paradoxes of Altcoin Season in September

Analyses and data indicate that the crypto market is experiencing its most active altcoin season since early 2025, with many altcoins outperforming Bitcoin. However, behind this excitement lies a paradox. Most retail investors remain uneasy as their portfolios show little to no profit.

This article outlines the main reasons behind this situation.

Altcoin Market Cap Rises but Dominance Shrinks

Sponsored

TradingView data shows that the TOTAL3 market cap (excluding BTC and ETH) reached a new high of over $1.1 trillion in September.

Yet the share of OTHERS (excluding the top 10) has declined since 2022, now standing at just 8%.

OTHERS Dominance And TOTAL3 Capitalization. Source: TradingView.

In past cycles, such as 2017 and 2021, TOTAL3 and OTHERS.D rose together. That trend reflected capital flowing not only into large-cap altcoins but also into mid-cap and low-cap ones.

The current divergence shows that capital is concentrated in stablecoins and a handful of top-10 altcoins such as SOL, XRP, BNB, DOG, HYPE, and LINK. Smaller altcoins receive far less liquidity, making it hard for their prices to return to levels where investors previously bought. This creates a situation where only a few win while most face losses.

Retail investors also tend to diversify across many coins instead of adding size to top altcoins. That explains why many portfolios remain stagnant despite a broader market rally.

Sponsored

Altcoin Index Surges but Investor Sentiment Remains Cautious

The Altcoin Season Index from Blockchain Center now stands at 80 points. This indicates that over 80% of the top 50 altcoins outperformed Bitcoin in the past 90 days—a clear sign of altcoin season.

However, the Fear & Greed Index is at 52, a neutral level reflecting caution and no clear directional bias.

The Altcoin Season Index & Fear & Greed Index. Source: Blockchain Center & Alternative

Sponsored

Historical data shows that the 2024 rally drove both indicators higher. At that time, the Altcoin Season Index climbed above 75, while the Fear & Greed Index soared past 80, showing extreme greed. The parallel rise reflected investor confidence as capital rotated strongly into altcoins. But that is not happening now.

Retail caution seems to stem from lessons learned in past cycles, where altcoins spiked then collapsed rapidly due to FOMO and mass sell-offs. New factors such as Fed rate decisions, tax impacts, and geopolitical tensions may also contribute to hesitation.

The Number of Altcoins Has Increased Tenfold Since 2021

Although the TOTAL3 market cap is near its 2021 peak, the context has changed dramatically. CoinMarketCap reports that in 2025, more than 21 million altcoins will be tracked—100 times more than the roughly 20,000 coins in 2021.

Sponsored

Total Altcoin Tracked. Source: CoinmarketCap

Dune data highlights the token explosion from 2017 to 2025, with unique tokens skyrocketing, especially on Ethereum, Solana, and Base.

This creates a much more selective environment. In 2021, investors could profit more easily with fewer coins because competition was lower. With tens of millions of tokens spanning DeFi, meme coins, and AI tokens, picking the right one is as difficult as finding a needle in a haystack.

Most new tokens fail quickly due to low liquidity, rug pulls, or intense competition. Retail investors, who often spread capital across many small-cap tokens, now face higher risks. This results in either losses or very modest returns, even as the overall market surges.

These three factors explain why the September 2025 altcoin season feels incomplete. To overcome this, investors may need deeper research, a focus on fundamentally strong projects, and a reconsideration of excessive diversification.

Source: https://beincrypto.com/why-many-portfolios-still-show-no-profit-amid-altcoin-season/

Aviso legal: Los artículos republicados en este sitio provienen de plataformas públicas y se ofrecen únicamente con fines informativos. No reflejan necesariamente la opinión de MEXC. Todos los derechos pertenecen a los autores originales. Si consideras que algún contenido infringe derechos de terceros, comunícate con service@support.mexc.com para solicitar su eliminación. MEXC no garantiza la exactitud, la integridad ni la actualidad del contenido y no se responsabiliza por acciones tomadas en función de la información proporcionada. El contenido no constituye asesoría financiera, legal ni profesional, ni debe interpretarse como recomendación o respaldo por parte de MEXC.
Compartir perspectivas

También te puede interesar

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Compartir
BitcoinEthereumNews2025/09/18 06:29
Compartir